Alice Sherrard
Chromatin Regulation Group Leader
Alice Sherrard is a Group Leader at CRUK Manchester institute, leading the Chromatin Regulation group. Their lab aims to understand the mechanisms that regulate chromatin structure to drive lineage decisions in the context of mammalian development and cancer.
About Dr Alice Sherrard
Alice completed her PhD at the University of Bristol in 2019, where she worked with the lab of Robert Grosse and identified a role for nuclear F-actin in de-condensing chromatin and expanding the nucleus after cell division.
For her postdoctoral studies, Alice first joined the lab of Clodagh O’Shea at the Salk Institute for Biological Studies in San Diego, and in 2020 moved to Yale University in the lab of Antonio Giraldez. Through her postdoctoral research, Alice developed cutting-edge electron microscopy methods to label specific proteins and quantify the associated nucleosome-scale structure by electron and cryo-electron microscopy. This identified chromatin signatures linked to stages of mouse embryonic development and defined a conserved role for Lamin A/C in regulating the first lineage decision in the mammalian embryo.
Applying these methods to study chromatin changes during Zygotic Genome Activation (ZGA), Alice identified five key structural subclasses of chromatin and revealed a role of high chromatin packing in early transcriptional activation.
To support this work, Alice secured funding from National Institute of Health for Child Health and Development in 2025 (K99/R00 grant) and was awarded an EMBO long-term postdoctoral fellowship.
She further received prizes from the Society of Developmental Biology (SDB) and the International Society of Stem Cell Research (ISSCR), and lead and obtained funding for several major outreach initiatives.
Qualifications
- PhD (January 2019), University of Bristol
- BSc (July 2015), University of Bristol
Interests
- Chromatin
- Imaging
- Cell plasticity
Publications
Why I work at CRUK MI
“The CRUK Manchester Institute stands out as a leading environment to transform cutting-edge basic research into real breakthroughs for cancer patients. “
Get in touch
All Institute Publications
https://www.nature.com/articles/s42255-026-01514-y
Tissue-specific fibroblast lipid cues impose the rate of epithelial cancer invasion
27 April 2026
Institute Authors (4)
Amaya Virós, Noah Palombo, Charlotte Russell, Claus Jørgensen
Research Group
Skin Cancer & Ageing
27 April 2026
https://www.cell.com/cancer-cell/fulltext/S1535-6108(26)00114-5
Immunometabolic gatekeeping: How tissue metabolism conditions tumor immunity
13 April 2026
Institute Authors (1)
Samra Turajlić
Research Group
Cancer Dynamics
13 April 2026
https://www.nature.com/articles/s41467-026-69964-2
Disruption of tRNA threonylation triggers RIG-I mediated anti-tumour immune response
25 February 2026
Institute Authors (1)
Sylvain Delaunay
Research Group
RNA Dynamics in Cancer
25 February 2026
https://doi.org/10.1038/s44161-025-00740-z
Single-cell profiling reveals three endothelial-to-hematopoietic transitions with divergent isoform expression landscapes
11 November 2025
Institute Authors (6)
Robert Sellers, John Weightman, Wolfgang Breitwieser, Natalia Moncaut, Michael Lie-a-ling, Georges Lacaud
Labs & Facilities
Computational Biology Support, Molecular Biology, Genome Editing and Mouse Models
Research Group
Stem Cell Biology
11 November 2025
https://doi.org/10.1136/jitc-2025-012527
Systemic immunosuppression from ultraviolet radiation exposure inhibits cancer immunotherapy
31 October 2025
Institute Authors (4)
Isabella Mataloni, Antonia Banyard, Garry Ashton, Amaya Virós
Labs & Facilities
Mass and Flow Cytometry, Histology
Research Group
Skin Cancer & Ageing
31 October 2025
https://aacrjournals.org/cancerdiscovery/article/doi/10.1158/2159-8290.CD-24-1224/766638/Glucocorticoids-Unleash-Immune-dependent-Melanoma
Glucocorticoids Unleash Immune-dependent Melanoma Control through Inhibition of the GARP/TGF β Axis
15 October 2025
Institute Authors (12)
Charles Earnshaw, Poppy Dunn, Shih-Chieh Chiang, Maria Koufaki, Massimo Russo, Kimberley Hockenhull, Erin Richardson, Anna Pidoux, Alex Baker, Richard Reeves, Robert Sellers, Sudhakar Sahoo
Labs & Facilities
Computational Biology Support, Visualisation, Irradiation and Analysis
Research Group
Cancer Inflammation and Immunity
15 October 2025
Our vision for world leading cancer research in the heart of Manchester
We are a leading cancer research institute within The University of Manchester, spanning the whole spectrum of cancer research – from investigating the molecular and cellular basis of cancer, to translational research and the development of therapeutics.
Our collaborations
Bringing together internationally renowned scientists and clinicians
Scientific Advisory Board
Supported by an international Scientific Advisory Board



